23andMe Sale Shows Your Genetic Data Is Worth $17
Monday, the genetic pharmaceutical company Regeneron announced that it is buying genetic sequencing company 23andMe out of bankruptcy for $256 million. The purchase gives us a rough estimate for the current monetary value of a single person’s genetic data: $17. Regeneron is a drug company that “intends to acquire 23andMe’s Personal Genome Service (PGS), Total…
